Cancer Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Cancer Clinical Trials in Brazil

Cancer Clinical Trials in Brazil – Top CROs en Latin America

Cancer, a widespread disease that affects millions globally, has prompted significant advancements in clinical trials and treatment options. In Brazil, clinical trials play a crucial role in the fight against cancer, offering patients access to cutting-edge therapies, innovative treatment approaches, and the potential for improved outcomes.

In this blog, we will explore the realm of cancer clinical trials in Brazil, highlighting their significance, ongoing initiatives, and the transformative impact they have on cancer care in the country.

The Significance of Cancer Clinical Trials

Clinical trials are essential for advancing medical knowledge, refining treatment protocols, and introducing novel therapies. In the context of cancer, clinical trials provide opportunities to evaluate the effectiveness and safety of new drugs, surgical techniques, radiation therapies, and immunotherapies.

They offer hope to patients by providing access to innovative treatments and contributing to the collective understanding of cancer.

Brazil’s Commitment to Cancer Clinical Trials

Brazil has made significant strides in cancer research, with a strong commitment to conducting clinical trials. The Brazilian government, along with academic institutions, hospitals, and pharmaceutical companies, has established a robust infrastructure to facilitate clinical trials and promote collaboration among researchers, clinicians, and patients.

These efforts aim to expand treatment options, improve patient outcomes, and position Brazil as a prominent contributor to global oncology research.

Cancer Clinical Trials in Brazil

Cancer Clinical Trials in Brazil

Notable Cancer Clinical Trials in Brazil

Brazil is actively involved in numerous cancer clinical trials across various therapeutic areas. These trials encompass a wide range of cancer types, including breast, lung, colorectal, and prostate cancers, among others.

Additionally, immunotherapy trials utilizing immune checkpoint inhibitors and CAR-T cell therapies have shown promising results in treating hematological malignancies and solid tumors. Brazil’s diverse population and large patient pool offer unique opportunities for conducting clinical trials with increased inclusivity and diversity.

Challenges and Opportunities

While cancer clinical trials in Brazil have seen significant progress, they also face challenges. Limited patient awareness about the availability and benefits of clinical trials, along with regulatory and logistical hurdles, can impact enrollment rates.

However, these challenges also present opportunities for increased patient education, healthcare provider engagement, and advocacy efforts to raise awareness and improve the overall clinical trial landscape in Brazil.

Shaping the Future of Cancer Care: Clinical Trials in Brazil

The future of cancer clinical trials in Brazil holds tremendous potential. Continued investment in research infrastructure, collaborations with international institutions, and the integration of precision medicine and genomic profiling into clinical trials will lead to personalized treatment approaches.

By leveraging innovative technologies and biomarkers, clinical trials can pave the way for tailored therapies and improved outcomes for patients across diverse populations in Brazil.

Conclusion

Cancer clinical trials in Brazil are instrumental in advancing cancer care and offering hope to patients fighting this challenging disease. Through active participation in clinical trials and support for research initiatives, Brazil is making significant contributions to global oncology advancements.

By fostering collaboration, patient education, and advocacy, we can continue to expand access to innovative treatments, refine treatment approaches, and ultimately work towards a future where cancer becomes a more manageable and curable condition in Brazil and beyond.

Cancer Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Cancer Clinical Trials in Brazil

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Cancer Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Cancer Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Cancer Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Cancer Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Cancer Clinical Trials in Brazil

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Cancer Clinical Trials in Brazil

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Cancer Clinical Trials in Brazil

The Cohortias Team

Cancer Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Cancer Clinical Trials in Brazil

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe